ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 22 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,413,000 | +246.5% | 3,107,000 | +234.1% | 0.10% | +264.3% |
| Q3 2018 | $985,000 | -6.1% | 930,000 | 0.0% | 0.03% | -17.6% |
| Q2 2018 | $1,049,000 | -80.0% | 930,000 | -80.7% | 0.03% | -79.9% |
| Q1 2018 | $5,251,000 | +33.9% | 4,816,000 | +41.0% | 0.17% | +11.9% |
| Q4 2017 | $3,922,000 | +78.0% | 3,416,000 | +68.3% | 0.15% | +106.8% |
| Q3 2017 | $2,203,000 | +3.3% | 2,030,000 | 0.0% | 0.07% | +12.3% |
| Q2 2017 | $2,132,000 | +52.0% | 2,030,000 | +52.6% | 0.06% | +80.6% |
| Q1 2017 | $1,403,000 | – | 1,330,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 37,284 | $42,692,000 | 2.46% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $9,120,000 | 0.79% |
| LINDEN ADVISORS LP | 4,500,000 | $5,156,000 | 0.61% |
| Perceptive Advisors | 7,500,000 | $8,488,000 | 0.51% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,000,000 | $1,144,000 | 0.45% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,211,000 | $17,425,000 | 0.40% |
| Hudson Bay Capital Management LP | 10,500,000 | $12,052,000 | 0.36% |
| Penn Capital Management Company, LLC | 4,977,000 | $5,674,000 | 0.23% |
| Visium Asset Management, LP | 6,500,000 | $7,471,000 | 0.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,000,000 | $6,840,000 | 0.09% |